Avoro Capital Advisors LLC raised its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 133.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,333,333 shares of the company’s stock after buying an additional 1,333,333 shares during the […]
SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and
Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional American Depositary Shares tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
SAN FRANCISCO, June 05, 2024 Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary.
Structure Therapeutics (GPCR) Announces Pricing of Upsized $476 Million Public Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.